Efedra Pharmaceuticals Pvt. Ltd.
Home
About Us
Products
Careers
Contact Us
Sulbactam reduces the minimum inhibitory concentrations (MICs) of Cefoperazone by 4-fold.
Therapeutic indications:
Respiratory tract infections (upper and lower)
Urinary tract infections
Peritonitis, cholecystitis, cholangitis, and other intra-abdominal infections
Septicemia
Meningitis
Skin and soft tissue infections
Bone and joint infections
Pelvic inflammatory disease, endometritis, gonorrhoea, and other infections of the genital tract
Duodenal Ulcer Disease in Adults
Sulbactam reduces the minimum inhibitory concentrations (MICs) of Cefoperazone by 4-fold.
2:1 ratio of CZONE-S results in longer T>MIC, resulting in greater kill ratio.
Empirical Cefoperazone-Sulbactam monotherapy could be a useful adjunct to surgical intervention for intra-abdominal infections
Daily Dosage:
Daily dosage recommendations for Sulbactam/Cefoperazone in adults 3-6 gm should be administered every 12 hours in equally divided doses.
The recommended maximum daily dosage of Sulbactam is 4g.
Patients with creatinine clearances between 15 and 30 mL/min - maximum daily dosage of 2 g Sulbactam.
Patients with creatinine clearances of less than 15 mL/min - maximum daily dosage of 1g Sulbactam.
Dose modification may be necessary in cases of severe biliary obstruction, severe hepatic disease